 Virios Therapeutics, Inc. NASDAQ:VIRI Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Greg Duncan - CEO Ralph Grosswald - SVP, Operations Angela Walsh - SVP, Finance Treasurer Dr. Mike Gendreau - Chief Medical Officer Conference Call Participants Sean Lee - H.C. Wainwright Co., LLC Operator Good day, and welcome to the Virios Therapeutics, Inc. Q3 Earnings Update. 